Acadia Healthcare stock gains as index weight and growth outlook support momentum

Published on 09/17/2026 at 19:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Acadia Healthcare stock appears among top positions in a major US value index at USD 28.77 as of September 17, 2026. Zacks sees earnings rising 14.4 percent by 2027 with steady revenue growth from mental health demand.

ACHC, US0048111059, Illustration mit AI erstellt.

Acadia Healthcare Company, Inc. (ISIN US0048111059) stock is trading firmly supported by its role in a major US value index, where the shares were quoted at USD 28.77 on September 17, 2026, reflecting a 2.17 percent daily gain and a 2.05 percent index weight as of that date.

Index position highlights investor interest

According to Public app on September 17, 2026, Acadia Healthcare appears as a position in the S&P Composite 1500 Pure Value Index, classified under Medical/Nursing Services with a price of USD 28.77, a daily change of plus 2.17 percent and a weight of 2.05 percent in that index.

This visible role in a diversified US value benchmark underlines that Acadia Healthcare stock is not only traded individually on its primary exchange but also embedded in systematic portfolios that track the index, which can help stabilize demand for the shares when value and health care themes attract capital.

Earnings outlook points to gradual recovery

As Zacks Equity Research reported on September 17, 2026, Acadia Healthcare is expected to earn USD 1.55 per share in fiscal year 2026, with the consensus estimate for 2027 standing at USD 1.78 per share, implying a 14.4 percent year-over-year increase in earnings.

The same Zacks overview states that consensus marks for Acadia Healthcare revenues point to 3.4 percent growth in 2026 and 5.4 percent growth in 2027, reflecting moderate top-line expansion as demand for mental health and substance use treatment remains strong in its operating markets.

Zacks notes that Acadia Healthcare has beaten earnings estimates in each of the past four quarters with an average surprise of 47 percent, which indicates that recent execution has been better than analysts expected and supports the view that strategic actions after past operational setbacks are gaining traction.

Business model anchored in behavioral health demand

According to the industry commentary from Zacks Equity Research, Acadia Healthcare is headquartered in Franklin, Tennessee and operates acute inpatient psychiatric facilities and Comprehensive Treatment Centers that focus on mental health and substance use treatment.

The same analysis highlights that higher patient days and rising admissions continue to support Acadia Healthcare results, while a valuable real estate portfolio and healthy cash generation give the company financial flexibility to invest in growth and operational improvements.

For investors, the combination of a steadily growing revenue base, a forecast double-digit earnings increase between 2026 and 2027 and participation in a broad value index suggests that Acadia Healthcare stock is positioned as a behavioral health play with both cyclical and defensive elements.

Stock price context and investor takeaway

On September 17, 2026, data from the S&P Composite 1500 Pure Value Index overview indicated a price of USD 28.77 for Acadia Healthcare, and the 2.17 percent gain on that day points to a positive short-term reaction in a value-oriented portfolio environment rather than an isolated move.